Exclusive

Publication

Byline

Location

Australian-New Zealand Clinical Trial: A rapid assessment and treatment pathway using targeted therapy and immunotherapy for people with anaplastic thyroid cancer

Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘A rapid assessment and treatment pathway using targeted therapy and ... Read More


Australian-New Zealand Clinical Trial: Social prescribing program for adults receiving dialysis

Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Social prescribing program for adults receiving dialysis’. The follo... Read More


Australian-New Zealand Clinical Trial: Better matching care to the needs of patients with musculoskeletal pain: the MATCH trial

Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Better matching care to the needs of patients with musculoskeletal p... Read More


Australian-New Zealand Clinical Trial: Pain relief in patients undergoing skin graft surgery using a local anesthetic dressing compared with a saline dressing at the donor site within 24 hours

Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Pain relief in patients undergoing skin graft surgery using a local ... Read More


Australian-New Zealand Clinical Trial: The Dance for Me Study: Testing a Dance Exercise Program for People with Endometriosis

Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘The Dance for Me Study: Testing a Dance Exercise Program for People ... Read More


Singapore Clinical Trial: A Phase II, Open-label Platform Study of Osimertinib in Combination with Anti-cancer Agents in Participants With EGFR-mutated Metastatic Non-small Cell Lung Cancer Whose Disease Has Progressed on Prior Osimertinib and Chemotherapy Combination Treatment (GROVE)

Singapore, Nov. 4 -- The Health Sciences Authority received information related to the study titled 'A Phase II, Open-label Platform Study of Osimertinib in Combination with Anti-cancer Agents in Part... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+, HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

Singapore, Nov. 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-... Read More


Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Nov. 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabilit... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Nov. 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety o... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4174794 in Participants with Obesity or Overweight who are Otherwise Healthy

Singapore, Nov. 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to E... Read More